This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Blue Cross Blue Shield, Blue Shield of California file reply in support of final judgment in testing-services antitrust litigation

( May 14, 2014, 17:07 GMT | Official Statement) -- MLex Summary: Blue Shield of California and the Blue Cross Blue Shield Association have filed a reply in support of their motion for entry of final judgment in a case alleging that Blue Shield and Aetna conspired with Quest Diagnostics to restrain competition in the sale of routine, molecular, and specialty services. The reply argues that there are no allegations of below-cost pricing — the basis for the remaining claims against Quest — with respect to either Blue Shield or BCBSA. See document below. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections